CVS Health to buy Target's pharmacy business for $1.9 billion
By Sruthi Ramakrishnan and Nathan Layne
(Reuters) - Drugstore operator CVS Health Corp (CVS.N: Quote) will buy Target Corp's (TGT.N: Quote) pharmacies and clinics in a $1.9 billion deal that should help it bargain with drug makers for lower prices, while freeing Target from a costly business where it struggled to make a profit.
CVS, the second-largest U.S. drugstore operator with 7,800 stores, said on Monday it will acquire Target's more than 1,660 pharmacies in 47 states with about $4 billion in annual sales. It will also acquire Target's nearly 80 clinics.
The pharmacies will continue to be located within Target stores but carry the CVS brand.
The move was the CVS' second large acquisition in as many months, coming on the heels of its $10.1 billion deal for healthcare services firm Omnicare Inc OCR.N in May.
The transaction will significantly expand the drugstore chain's retail presence and should bolster its bargaining power with pharmaceutical companies.
"The healthcare industry is evolving rapidly," CVS Chief Executive Larry Merlo said on a conference call. "In this environment, success is all about effectively managing costs, quality and access."
For Target, the deal divests a business that was "modestly negative" in terms of profits. While Target will lose revenue, its sales, general and administrative costs will drop by $1 billion.
Target Chief Executive Brian Cornell said the move fits with the company's focus on a handful of categories where it believes it can be most competitive including apparel, items for children and health and wellness-related goods. Target will continue to handle the sale of over-the-counter drugs. Continued...